Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.

Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published...

Rocket Pharmaceuticals drops despite the FDA's accelerated approval of gene therapy Kresladi in severe leukocyte adhesion deficiency-I, an ultra-rare...

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, 2026, in Immunity &...

bCancer-fighting immune cells may soon be engineered directly inside the body, removing the need for complex lab-based manufacturing./b Researchers

For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their brain activity may begin...

OCGN stock falls after phase II data for OCU410 show lower lesion reduction than earlier results, despite 31% improvement in the eye disease study.

CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX |...

CRANBURY, N.J.--(BUSINESS WIRE)--Mar. 27, 2026-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated biotechnology company advancing a...

Our immune cells usually fight off covid-19, but in some cases, things go rogue SCIENCE PHOTO LIBRARY Evidence is mounting that long covid can be...